PMC:7243768 / 29468-29677 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1151","span":{"begin":61,"end":65},"obj":"Gene"},{"id":"1152","span":{"begin":186,"end":190},"obj":"Gene"},{"id":"1153","span":{"begin":199,"end":203},"obj":"Gene"},{"id":"1166","span":{"begin":136,"end":146},"obj":"Chemical"},{"id":"1167","span":{"begin":151,"end":159},"obj":"Chemical"}],"attributes":[{"id":"A1151","pred":"tao:has_database_id","subj":"1151","obj":"Gene:59272"},{"id":"A1152","pred":"tao:has_database_id","subj":"1152","obj":"Gene:59272"},{"id":"A1153","pred":"tao:has_database_id","subj":"1153","obj":"Gene:59272"},{"id":"A1166","pred":"tao:has_database_id","subj":"1166","obj":"MESH:D017706"},{"id":"A1167","pred":"tao:has_database_id","subj":"1167","obj":"MESH:D019808"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"sin II activity or synthesis mediated the augmented level of ACE2 expression and its activity in cardiac. Still, the combination of the lisinopril and losartan increases the activity of ACE2 but not ACE2 mRNA."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T268","span":{"begin":204,"end":208},"obj":"Body_part"}],"attributes":[{"id":"A268","pred":"fma_id","subj":"T268","obj":"http://purl.org/sig/ont/fma/fma67122"}],"text":"sin II activity or synthesis mediated the augmented level of ACE2 expression and its activity in cardiac. Still, the combination of the lisinopril and losartan increases the activity of ACE2 but not ACE2 mRNA."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T411","span":{"begin":7,"end":15},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T412","span":{"begin":85,"end":93},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T413","span":{"begin":174,"end":182},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"sin II activity or synthesis mediated the augmented level of ACE2 expression and its activity in cardiac. Still, the combination of the lisinopril and losartan increases the activity of ACE2 but not ACE2 mRNA."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T142","span":{"begin":4,"end":6},"obj":"Chemical"},{"id":"T143","span":{"begin":136,"end":146},"obj":"Chemical"},{"id":"T144","span":{"begin":151,"end":159},"obj":"Chemical"}],"attributes":[{"id":"A142","pred":"chebi_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A143","pred":"chebi_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/CHEBI_43755"},{"id":"A144","pred":"chebi_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/CHEBI_6541"}],"text":"sin II activity or synthesis mediated the augmented level of ACE2 expression and its activity in cardiac. Still, the combination of the lisinopril and losartan increases the activity of ACE2 but not ACE2 mRNA."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T45","span":{"begin":19,"end":28},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":"sin II activity or synthesis mediated the augmented level of ACE2 expression and its activity in cardiac. Still, the combination of the lisinopril and losartan increases the activity of ACE2 but not ACE2 mRNA."}

{"project":"LitCovid-sentences","denotations":[{"id":"T199","span":{"begin":106,"end":209},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"sin II activity or synthesis mediated the augmented level of ACE2 expression and its activity in cardiac. Still, the combination of the lisinopril and losartan increases the activity of ACE2 but not ACE2 mRNA."}